Su questa pagina
GYRE Gyre Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 7, 2026
$7,11
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$5,44minimo 52 sett.
$9,42massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$754M
P/E (TTM)
-35.5
EPS (TTM)
$-0.20
Ricavi (TTM)
$119M
i tuoi badge
Intervallo 52 sett.
$5–$9
Rating Analisti
BUY
Prezzo Obiettivo
$19
P/E
-35.5
ROE
-28.3%
Margine di Profitto Netto
-23.7%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
GYRE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$7.11
Capitalizzazione di Mercato (MRQ)
$754M
P/E (TTM)
-35.5
EPS (TTM)
$-0.20
Ricavi (TTM)
$119M
ROE (TTM)
-28.3%
Intervallo 52 sett.
$5–$9
GYRE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 31 Ottobre 2023 | 1-for-15 | Inverso |
| 13 Febbraio 2017 | 1-for-15 | Inverso |
| 21 Agosto 2015 | 1-for-7 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$117M2017-12-31 → 2025-12-31
EPS$0.022021-12-31 → 2025-12-31
Flusso di cassa libero$-180.0K2016-12-31 → 2025-12-31
Margine netto-23.7%2020-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | GYRE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -35.5media 5 anni ≈167.4 | ≈167.4 | · | · | |
| P/S (TTM) | 6.3media 5 anni ≈8.9 | ≈8.9 | 8.0 | Sottovalutato | |
| P/B (MRQ) | 7.0media 5 anni ≈-28.9 | ≈-28.9 | 3.2 | Sopravvalutato | |
| Prezzo / FCF (TTM) | -47.9media 5 anni ≈-1214.5 | ≈-1214.5 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -52.0media 5 anni ≈104.6 | ≈104.6 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 7.3media 5 anni ≈10.1 | ≈10.1 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | GYRE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -14.0%media 5 anni ≈-11.4% | ≈-11.4% | -1043.3% | Di prim'ordine | |
| Margine EBITDA (TTM) | -11.1%media 5 anni ≈-9.9% | ≈-9.9% | -1043.3% | Di prim'ordine | |
| Margine ante imposte (TTM) | -13.5%media 5 anni ≈-11.2% | ≈-11.2% | · | · | |
| Margine di Profitto Netto (TTM) | -23.7%media 5 anni ≈-16.7% | ≈-16.7% | -989.0% | Di prim'ordine | |
| ROA (TTM) | -16.1%media 5 anni ≈-20.7% | ≈-20.7% | -33.0% | Di prim'ordine | |
| ROE (TTM) | -28.3%media 5 anni ≈65.0% | ≈65.0% | -39.4% | Di prim'ordine | |
| ROIC | 7.4%media 5 anni ≈135.1% | ≈135.1% | -32.0% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | GYRE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 4.3media 5 anni ≈3.4 | ≈3.4 | 11.3 | Bassa liquidità | |
| Quick Ratio (MRQ) | 3.0media 5 anni ≈2.5 | ≈2.5 | 6.6 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | GYRE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 10.2%media 5 anni ≈248.7% | ≈248.7% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 4.5%media 5 anni ≈74.5% | ≈74.5% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 41.0% | · | · | · | |
| EPS YoY | -60.0% | · | · | · | |
| Net Income YoY (Utile Netto YoY) | -44.8% | · | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | -12.6% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | 31.8% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | GYRE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.8media 5 anni ≈0.9 | ≈0.9 | 0.0 | Di prim'ordine | |
| Receivables Turnover (Rotazione dei crediti) | 4.6 | · | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$186.5K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Pagamento annualizzato≈$3.60
| Data ex-dividendo | Importo | Valuta | Rendimento |
|---|---|---|---|
| Gen 13, 2023 | $3,60 | USD | ≈642.3% |
| Set 21, 2022 | $21,45 | USD | ≈286.0% |
| Ago 20, 2015 | $896,18 | USD | ≈59.3% |
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
13.3%
Prossimo report
Nov 05, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 18, 2026 | $-0.12 | $-0.09 | -30.7% |
| 31 Marzo 2026 | Mag 8, 2026 | $-0.10 | $-0.07 | -33.7% |
| 31 Dicembre 2025 | $0.05 | $0.06 | -13.5% | |
| 30 Settembre 2025 | $0.08 | $0.03 | 194.1% | |
| 30 Giugno 2025 | $0.02 | $0.03 | -34.6% | |
| 31 Marzo 2025 | $0.03 | $0.03 | -2.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $0.73 | $-0.21 | $-0.57 | · | $3.44 | $5.68 | · | $5.06 | $20.04 | $2.75 | $3.23 | |
| Revenue / Share | $1.13 | $1.03 | $1.72 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.01 | $-0.04 | $0.39 | $-1.05 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.41 | $0.14 | $0.44 | $0.57 | · | $1.37 | $1.28 | · | $2.38 | $12.80 | $2.55 | $1.67 | |
| Dividend / Share | · | · | · | $0.24 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | · | $1.43 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | · | 90,850,040 | 89,119,344 | 86,420,530 | · | 85,643,646 | 85,502,403 | 83,265,879 | · | 63,588,119 | 63,588,119 | 63,588,119 | · | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | · | 103,971,546 | 89,203,138 | 101,970,672 | · | 102,640,373 | 102,205,888 | 102,594,197 | · | 78,904,324 | 78,904,324 | 78,921,366 | · | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.11 | · | $1.12 | $1.01 | $0.78 | · | $0.74 | $0.71 | $0.66 | · | $0.09 | $-0.75 | $-0.69 | · | $0.93 | |
| Revenue / Share | · | $0.25 | · | $0.29 | $0.26 | $0.22 | · | $0.25 | $0.24 | $0.26 | · | · | · | · | · | · | |
| Cash Flow / Share | · | $0.03 | · | · | · | $-0.00 | · | · | · | $0.03 | · | · | · | $-0.16 | · | · | |
| Cash / Share | · | $0.41 | · | $0.44 | $0.40 | $0.17 | · | $0.18 | $0.19 | $0.35 | · | $0.06 | $0.18 | $0.21 | · | $0.73 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.24 | · | $1.43 | |
| EPS (TTM) | $-0.22 | $-0.11 | · | $0.00 | $-0.02 | $0.02 | · | $-1.46 | $-1.42 | $-1.41 | · | $-0.89 | $-1.10 | $0.52 | · | $0.38 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $120M | · | $110M | $105M | $101M | · | $105M | $112M | $116M | · | · | · | · | · | · | |
| Net Income TTM | $-29M | $-16M | · | $9M | $6M | $13M | · | $-84M | $-79M | $-80M | · | $-12M | $-25M | $23M | · | $12M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -63.4 | · | · | -367.5 | 386.0 | · | -8.6 | -8.4 | -12.4 | · | -8.1 | -4.8 | 6.1 | · | 19.7 | |
| P/S | · | 5.3 | · | 6.2 | 6.3 | 6.7 | · | 10.2 | 9.1 | 12.9 | · | · | · | · | · | · | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| Earnings Yield | -3.3% | -1.6% | · | 0.00% | -0.27% | 0.26% | · | -11.6% | -11.9% | -8.1% | · | -12.4% | -20.9% | 16.5% | · | 5.1% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $117M | $106M | $113M | $102M | $7M |
| Margine Lordo % | · | 96.3% | 95.9% | · | · |
| Margine Operativo % | 9.8% | 15.3% | -59.3% | · | · |
| Utile netto | $10M | $18M | $-85M | $4M | $-88M |
| EPS Diluito | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 5.6 | 3.3 | 2.9 | 1.7 | · |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-180.0K | $-6M | $17M | · | · |
Proprietari istituzionali (13F) 61 filer · $65.5M totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
61
Valore detenuto
$65.5M
Nuove posizioni
11
Posizioni chiuse
7
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 11 (-4 vs trimestre precedente) | 7 (+4 vs trimestre precedente) | 31 (+13 vs trimestre precedente) | 9 (-2 vs trimestre precedente) | +5.3M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| HSG Holding Ltd | $24.714.470 | 3.750.299 | 37,75% | Azioni |
| VANGUARD GROUP INC | $8.483.219 | 1.201.589 | 12,96% | Azioni |
| BlackRock, Inc. | $6.550.085 | 993.943 | 10,01% | Azioni |
| Octagon Capital Advisors LP | $6.289.601 | 954.416 | 9,61% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.778.949 | 876.927 | 8,83% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $3.513.176 | 532.950 | 5,37% | Azioni |
| STATE STREET CORP | $1.617.199 | 245.402 | 2,47% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.214.445 | 184.286 | 1,86% | Azioni |
| NORTHERN TRUST CORP | $1.117.249 | 169.537 | 1,71% | Azioni |
| SBI Securities Co., Ltd. | $1.098.883 | 166.750 | 1,68% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $995.571 | 151.073 | 1,52% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816.850 | 123.953 | 1,25% | Azioni |
| GOLDMAN SACHS GROUP INC | $568.289 | 86.235 | 0,87% | Azioni |
| Bank of New York Mellon Corp | $413.523 | 62.750 | 0,63% | Azioni |
| MORGAN STANLEY | $274.743 | 41.691 | 0,42% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $171.392 | 24.590 | 0,26% | Azioni |
| STRS OHIO | $170.022 | 25.800 | 0,26% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $166.516 | 25.268 | 0,25% | Azioni |
| Nuveen, LLC | $161.488 | 24.505 | 0,25% | Azioni |
| UBS Group AG | $123.649 | 18.763 | 0,19% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $121.836 | 18.488 | 0,19% | Azioni |
| DEUTSCHE BANK AG\ | $118.218 | 17.939 | 0,18% | Azioni |
| RHUMBLINE ADVISERS | $111.131 | 16.865 | 0,17% | Azioni |
| WELLS FARGO & COMPANY/MN | $107.397 | 16.297 | 0,16% | Azioni |
| FMR LLC | $98.679 | 14.974 | 0,15% | Azioni |
| ROYAL BANK OF CANADA | $87.000 | 13.195 | 0,13% | Azioni |
| BANK OF AMERICA CORP /DE/ | $82.539 | 12.525 | 0,13% | Azioni |
| Polymer Capital Management (US) LLC | $77.630 | 11.780 | 0,12% | Azioni |
| Vanguard Global Advisers, LLC | $65.788 | 9.983 | 0,10% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $59.382 | 9.011 | 0,09% | Azioni |
| CITIGROUP INC | $56.582 | 8.586 | 0,09% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55.659 | 8.446 | 0,09% | Azioni |
| JPMORGAN CHASE & CO | $50.510 | 7.831 | 0,08% | Azioni |
| Russell Investments Group, Ltd. | $24.930 | 3.783 | 0,04% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $22.973 | 3.486 | 0,04% | Azioni |
| BARCLAYS PLC | $21.273 | 3.228 | 0,03% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $17.793 | 2.700 | 0,03% | Azioni |
| Tower Research Capital LLC (TRC) | $16.271 | 2.469 | 0,02% | Azioni |
| Legal & General Group Plc | $13.536 | 2.054 | 0,02% | Azioni |
| Ameritas Investment Partners, Inc. | $4.501 | 683 | 0,01% | Azioni |
| Activest Wealth Management | $3.512 | 533 | 0,01% | Azioni |
| Arax Advisory Partners | $1.621 | 246 | 0,00% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.094 | 166 | 0,00% | Azioni |
| Sterling Capital Management LLC | $1.061 | 161 | 0,00% | Azioni |
| GAMMA Investing LLC | $962 | 146 | 0,00% | Azioni |
| CWM, LLC | $725 | 104 | 0,00% | Azioni |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0,00% | Azioni |
| Bare Financial Services, Inc | $521 | 79 | 0,00% | Azioni |
| GoalVest Advisory LLC | $367 | 50 | 0,00% | Azioni |
| OSAIC HOLDINGS, INC. | $288 | 44 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 21 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | 07 Maggio 2026 | 6,33% | Modifica | M&A / vendita | SEC |
| Ying Luo, Ping Lan | 06 Maggio 2026 | 8,60% | Modifica | M&A / vendita | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 depositi | 06 Maggio 2026 | 69,10% | Modifica | M&A / vendita | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | 06 Settembre 2024 | · | Deposito iniziale | Investimento passivo | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | 06 Settembre 2024 | · | Deposito iniziale | Investimento passivo | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 depositi | 31 Ottobre 2023 | · | Deposito iniziale | · | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 depositi | 07 Ottobre 2022 | · | Deposito iniziale | Investimento passivo | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 depositi | 22 Settembre 2022 | · | Deposito iniziale | · | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 depositi | 27 Gennaio 2022 | · | Deposito iniziale | · | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 depositi | 05 Agosto 2020 | · | Deposito iniziale | · | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 depositi | 17 Gennaio 2020 | · | Deposito iniziale | · | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | 14 Febbraio 2018 | · | Deposito iniziale | · | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 depositi | 09 Febbraio 2018 | · | Deposito iniziale | · | SEC |
| 23 Maggio 2017 | · | Deposito iniziale | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 depositi | 29 Marzo 2017 | · | Deposito iniziale | · | SEC |
| Essex Woodlands Health Ventures VIII, LLC, Essex Woodlands Health Ventures VIII, L.P., Essex Woodlands Health Ventures Fund VIII, L.P., Jeff Himawan, Ph.D., James Currie, Martin Sutter, Immanuel Thangaraj, Petri Vainio, Ron Eastman, Steve Wiggins, Guido Neels | 31 Agosto 2015 | · | Deposito iniziale | Investimento passivo | SEC |
| Morgenthaler Management Partners VIII, LLC, Morgenthaler Partners VIII, L.P., Ralph Christoffersen, Robert Bellas, John Lutsi, Gary Morgenthaler, Robert Pavey, Gary Little | 31 Agosto 2015 | · | Deposito iniziale | Investimento passivo | SEC |
| Rosetta Capital V LP, Rosetta Capital V GP LP, Rosetta Capital V GP Limited, Rosetta Capital Limited | 28 Agosto 2015 | · | Deposito iniziale | Investimento passivo | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BIOTECHNOLOGY VALUE FUND II, L.P., BVF INVESTMENTS, L.L.C., INVESTMENT 10, L.L.C., MSI BVF SPV, LLC, BVF PARTNERS, L.P., BFV INC., MARK N. LAMPERT ×6 depositi | 21 Agosto 2015 | · | Deposito iniziale | · | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 29 Gennaio 2008 | · | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 28 Gennaio 2008 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 66 insider · 26 dirigenti · 32 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | 08 Giugno 2026 A | 2.565.226 | 0 | 2 | $-82.927 |
| Han Ying | Chief Executive Officer | 14 Agosto 2024 A | · | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | 20 Novembre 2023 A | · | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | 04 Maggio 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | 04 Maggio 2026 A | 15.000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | 07 Gennaio 2026 A | · | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | 31 Agosto 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | 08 Febbraio 2021 A | · | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | 12 Agosto 2019 A | 3.744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | 14 Agosto 2015 A | 1.159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | 17 Ottobre 2014 A | 57.799 | 0 | 0 | $0 |
| Songjiang Ma | President | 28 Maggio 2025 S | 2.806.084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | 18 Giugno 2026 M | 700.000 | 0 | 16 | $-869.947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | 08 Giugno 2026 A | · | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | 09 Agosto 2022 P | 9.417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | 09 Agosto 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | 13 Marzo 2020 P | 7.353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | 22 Ottobre 2015 A | 31.008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | 14 Agosto 2015 A | 45.000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | 17 Ottobre 2014 A | 46.000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | 23 Gennaio 2014 A | · | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | 17 Gennaio 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | 17 Gennaio 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | 17 Gennaio 2013 A | 15.938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | 20 Settembre 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | 29 Marzo 2011 A | 1.153 | 0 | 0 | $0 |
| Claire Weston | Direttore | 03 Agosto 2026 A | · | 0 | 0 | $0 |
| Maxwell Kirkby | Direttore | 03 Agosto 2026 A | · | 0 | 0 | $0 |
| Dan Weng | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Ping Zhang | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Rodney L Nussbaum | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Renate Parry | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Gordon Carmichael | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| David M. Epstein | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Nassim Usman | Direttore | 28 Giugno 2024 M | 1.636 | 0 | 0 | $0 |
| Andrea Hunt | Direttore | 31 Agosto 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Direttore | 31 Agosto 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Direttore | 07 Gennaio 2022 A | 31.790 | 0 | 0 | $0 |
| Eddie Williams | Direttore | 07 Gennaio 2022 A | 34.804 | 0 | 0 | $0 |
| Errol B Desouza | Direttore | 01 Ottobre 2021 A | 29.801 | 0 | 0 | $0 |
| Jeanne Y Jew | Direttore | 09 Settembre 2021 A | · | 0 | 0 | $0 |
| Sharon Tetlow | Direttore | 09 Giugno 2021 A | 3.635 | 0 | 0 | $0 |
| John P Richard | Direttore | 13 Marzo 2020 P | 3.716 | 0 | 0 | $0 |
| Stephen A Hill | Direttore | 06 Settembre 2018 D | 1.190 | 0 | 0 | $0 |
| Harold E Selick | Direttore | 16 Gennaio 2018 A | 16.614 | 0 | 0 | $0 |
| Jeff Himawan | Direttore | 20 Agosto 2015 J | 1.179.352 | 0 | 0 | $0 |
| Alan W Dunton | Direttore | 14 Agosto 2015 A | 10.000 | 0 | 0 | $0 |
| Charles A Blixt | Direttore | 14 Agosto 2015 A | 10.000 | 0 | 0 | $0 |
| Julia R Brown | Direttore | 14 Agosto 2015 A | 10.000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Direttore | 07 Giugno 2013 A | 11.332 | 0 | 0 | $0 |
| Steven Burrill | Direttore | 31 Luglio 2012 M | 4.333 | 0 | 0 | $0 |
| Ralph Snyderman | Direttore | 07 Giugno 2012 A | 0 | 0 | 0 | $0 |
| Ann Hanham | Direttore | 18 Aprile 2006 C | 778.062 | 0 | 0 | $0 |
| GNI Hong Kong Ltd | Proprietario del 10% | 27 Ottobre 2023 J | 0 | 0 | 0 | $0 |
| Scott D. Sandell | Proprietario del 10% | 05 Dicembre 2013 S | 0 | 0 | 0 | $0 |
| Peter J Barris | Proprietario del 10% | 05 Dicembre 2013 S | 0 | 0 | 0 | $0 |
| James M Barrett | Proprietario del 10% | 03 Dicembre 2013 M | 0 | 0 | 0 | $0 |
| Richard C Kramlich | Proprietario del 10% | 19 Novembre 2012 X | 5.333 | 0 | 0 | $0 |
| NEA Partners 10, Limited Partnership | Proprietario del 10% | 17 Gennaio 2008 J | 4.563.512 | 0 | 0 | $0 |
| Iii Eugene A Trainor | Proprietario del 10% | 17 Gennaio 2008 J | 4.563.512 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | Proprietario del 10% | 17 Gennaio 2008 J | 4.563.512 | 0 | 0 | $0 |
| Mark W Perry | Proprietario del 10% | 17 Gennaio 2008 J | 4.563.512 | 0 | 0 | $0 |
| Charles W Newhall III | Proprietario del 10% | 17 Gennaio 2008 J | 4.563.512 | 0 | 0 | $0 |
| Peter Morris | Proprietario del 10% | 06 Febbraio 2007 M | 2.000 | 0 | 0 | $0 |
| Jeffrey P Brennan | · | 17 Gennaio 2013 A | 0 | 0 | 0 | $0 |
| Elaine V Jones | · | 29 Novembre 2007 X | 27.500 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 11 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWO · iShares Trust | 0,01% | 120.729 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,00% | 8.775 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 387.159 SH | 11 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 238.693 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 614.654 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 104.607 SH | 19 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.047 SH | 19 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.494 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 805 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 320 NS | 31 Luglio 2026 | N-PORT |
| IWN · iShares Trust | · | 41.397 SH | 11 Settembre 2026 | Giornaliero |
GYRE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 9 analisti
COMPRA
Target mediano
$18.00
+153,2%
3 33,3%
Acquisto forte
5 55,6%
Compra
1 11,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-10-02Target medio $18.67 +162,5%
← Sotto tutti i target
Prezzo attuale $7.11
Basso$18.00
Media$18.67
Alto$20.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| ACHV | · | -4.0 | · | · | · | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| FTH | · | · | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 7, 2026